Abstracts: Schizophrenia
Schizophrenia
- Antipsychotic monotherapy among outpatients with schizophrenia initiated on olanzapine or risperidone in Japan
- Circulating steroids are efficient predictors of schizophrenia
- Clinical and functional outcomes for patients with schizophrenia treated with olanzapine in Japan: One-year naturalistic outcomes for inpatients and outpatients
- Clinical trials for cognitive deficits in schizophrenia: Boom or Bust?
- Naturalistic Outcomes for Patients with Schizophrenia Treated with Olanzapine as Monotherapy or Antipsychotic Polypharmacy in Japan
- Predicting Continuation of Olanzapine in the 1-year Naturalistic Treatment of Patients with Schizophrenia in Japan
- Predictors of Antipsychotic Monotherapy with Olanzapine during a 1-Year Naturalistic Study of Schizophrenia Patients in Japan
- Preferential role of NR2A subunits in NMDA receptor antagonist-induced aberrant cortical gamma oscillations: relevance to cognitive deficits in schizophrenia
8 abstracts